A股異動 | *ST羅普復牌漲停 控股股東將變更為蘇州中恆
格隆匯4月14日丨*ST羅普(002333.SZ)復牌漲停,封單逾17萬手,報4.67元,暫成交82萬元,最新總市值23.5億元。*ST羅普昨日晚間公告,控股股東羅普斯金控股擬以每股8元的價格,協議轉讓公司1.5億股(佔公司總股本29.84%)給蘇州中恆投資有限公司,轉讓價款總額為12億元。公司同時披露定增預案,擬向蘇州中恆發行1.5億股,發行價3.37元/股,募資50550萬元,扣除發行費用後將全額用於補充公司流動資金。此次非公開發行完成後,公司控股股東及實際控制人將發生變更,公司控股股東將變更為蘇州中恆。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.